Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Cash from Financing Activities (2017 - 2025)

Catheter Precision (VTAK) has disclosed Cash from Financing Activities for 9 consecutive years, with $307000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities fell 93.13% to $307000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2025, down 38.19% year-over-year, with the annual reading at $5.3 million for FY2025, 38.19% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $307000.0 at Catheter Precision, down from $2.4 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $11.2 million in Q1 2022, with the low at -$516000.0 in Q2 2022.
  • Average Cash from Financing Activities over 5 years is $3.2 million, with a median of $2.4 million recorded in 2025.
  • The sharpest move saw Cash from Financing Activities plummeted 114.47% in 2021, then surged 6956.44% in 2022.
  • Over 5 years, Cash from Financing Activities stood at $141000.0 in 2021, then skyrocketed by 3592.2% to $5.2 million in 2022, then tumbled by 102.06% to -$107000.0 in 2023, then surged by 4276.64% to $4.5 million in 2024, then plummeted by 93.13% to $307000.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $307000.0, $2.4 million, and $2.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.